Safety and efficacy of different tirofiban administration routes on acute ischemic stroke patients with successful recanalization: A propensity score matching analysis.

CNS Neurosci Ther · 2022 · PMC9627363 · PMID 35962605

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Intriguingly, our results also showed a trend of a lower sICH rate in patients with IA + IV tirofiban or IV tirofiban compared with no tirofiban.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.